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Background: Over time, herbal plants and their various components have been major sources of therapeutic 
medicine for man. A comparative study was carried out to determine the phytochemical components and 
antibacterial activities of the different crude extracts of Euphorbia heterophylla and Vitellaria paradoxa roots on four 
enteric bacteria; Salmonella typhi, Shigella flexneri, Escherichia coli and Proteus vulgaris.  
Methodology: Root samples of E. heterophylla and V. paradoxa were collected, washed, air dried and processed to 
fine powder in the microbiology laboratory of Federal University of Technology, Minna, Nigeria. Crude extract of the 
root samples was done by the cold maceration technique using four solvents (chloroform, methanol, petroleum 
ether and water). Phytochemical analysis of the extracts was done using previously described technique, and in 
vitro antibacterial activities of different concentrations of the extracts (50-200 mg/ml) and a standard antibiotic 
(ciprofloxacin) were tested on four enteric bacteria (S. typhi, S. flexneri, E. coli, P. vulgaris) by the agar diffusion 
test. In vivo antibacterial activities of the two plants were also tested by daily oral administration of 2000 mg/kg 
bodyweight (for 7 days) of each extract on inbred mice infected through intraperitoneal inoculation of an infective 
dose of each of the four enteric bacteria. Data were computed as mean ± standard error and analysed by the 
Statistical Analysis System (SAS) version 9.4. Associations between variables were determined using analysis of 
variance (ANOVA), with p < 0.05 considered as significant value.   
Results: Phytochemical analysis of the crude extracts of both plants revealed the presence of cardiac glycosides, 
saponins, alkaloids, flavonoids, and tannins but V. paradoxa contain more carbohydrates and starch, and less 
phlobatannins, compared to E. heterophylla. In vitro assay showed dose-dependent antibacterial activity of the 
methanol, aqueous and chloroform (but not petroleum ether) extracts of the two plant roots. The in vitro 
antibacterial activities of the different extracts of V. paradoxica extracts were significantly higher (higher mean 
diameters of inhibition zones) than those of E. heterophylla (p<0.05), and methanol extracts gave the highest 
antibacterial effects. However, the root extract of E. heterophylla gave a higher antibacterial activity with the in 
vivo assay on inbred mice than V. paradoxa, and methanol extracts of the two plant extracts gave the highest in 
vivo activity, followed by aqueous extract and least activity was obtained with the chloroform extract.  
Conclusion: Crude extracts of E. heterophylla and V. paradoxa roots produce antibacterial activity against enteric 
Gram-negative bacteria pathogens involved in diarrhoea illnesses. Further researches should be directed towards 
isolation and characterization of the active compounds in the crude extracts. 
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Abstrait: 
Contexte: Au fil du temps, les plantes médicinales et leurs divers composants ont été une source majeure de 
médecine thérapeutique pour l'homme. Une étude comparative a été réalisée pour déterminer les composants 
phytochimiques et les activités antibactériennes des différents extraits bruts de racines d'Euphorbia heterophylla et 
de Vitellaria paradoxa sur quatre bactéries entériques; Salmonella typhi, Shigella flexneri, Escherichia coli et 
Proteus vulgaris.                            
Méthodologie: Des échantillons de racines d'E. heterophylla et de V. paradoxa ont été collectés, lavés, séchés à 
l'air et transformés en poudre fine dans le laboratoire de microbiologie de l'Université fédérale de technologie, 
Minna, Nigéria. L'extraction brute des échantillons de racines a été réalisée par la technique de macération à froid 
en utilisant quatre solvants (chloroforme, méthanol, éther de pétrole et eau). L'analyse phytochimique des extraits 
a été effectuée en utilisant la technique décrite précédemment, et les activités antibactériennes in vitro de 
différentes concentrations des extraits (50-200 mg/ml) et d'un antibiotique standard (ciprofloxacine) ont été 
testées sur quatre bactéries entériques (S. typhi, S. flexneri, E. coli, P. vulgaris) par le test de diffusion sur gélose. 
Les activités antibactériennes in vivo des deux plantes ont également été testées par administration orale 
quotidienne de 2000 mg/kg de poids corporel (pendant 7 jours) de chaque extrait sur des souris consanguines 
infectées par inoculation intrapéritonéale d'une dose infectieuse de chacune des quatre bactéries entériques. Les 
données ont été calculées en tant que moyenne ± erreur standard et analysées par le système d'analyse statistique 
(SAS) version 9.4. Les associations entre les variables ont été déterminées à l'aide d'une analyse de variance 
(ANOVA), avec p < 0,05 considéré comme une valeur significative.                            
Résultats: L'analyse phytochimique des extraits bruts des deux plantes a révélé la présence de glycosides 
cardiaques, de saponines, d'alcaloïdes, de flavonoïdes et de tanins mais V. paradoxa contient plus de glucides et 
d'amidon, et moins de phlobatannins, par rapport à E. heterophylla. Un essai in vitro a montré une activité 
antibactérienne dose-dépendante des extraits au méthanol, aqueux et au chloroforme (mais pas à l'éther de 
pétrole) des deux racines des plantes. Les activités antibactériennes in vitro des différents extraits d'extraits de V. 
paradoxica étaient significativement plus élevées (diamètres moyens des zones d'inhibition plus élevés) que celles 
d'E. heterophylla (p<0,05), et les extraits au méthanol ont donné les effets antibactériens les plus élevés. 
Cependant, l'extrait de racine d'E. heterophylla a donné une activité antibactérienne plus élevée avec le test in vivo 
sur des souris consanguines que V. paradoxa, et les extraits au méthanol des deux extraits de plantes ont donné 
l'activité in vivo la plus élevée, suivie par l'extrait aqueux et l'activité la plus faible a été obtenu avec l'extrait 
chloroformique.                                     
Conclusion: Des extraits bruts de racines d'E. heterophylla et de V. paradoxa produisent une activité 
antibactérienne contre les bactéries pathogènes entériques à Gram négatif impliquées dans les maladies 
diarrhéiques. D'autres recherches devraient être dirigées vers l'isolement et la caractérisation des composés actifs 
dans les extraits bruts. 




 Plants basically consist of 32% of the 
earth surface (1). There are about half a million 
plants now growing on earth, many of which 
possess therapeutic and pharmaceutical pro- 
perties (2). According to an earlier survey, 
about 25% of modern drugs and medicinal pro- 
ducts are derived from secondary metabolites 
of plant (3). Most of these plants are said to be 
beneficial in attaining stable health and treat- 
ment of most human diseases, and as such, 
are termed medicinal plants. Medicinal plants 
can be described as natures’ pharmacy for 
nearly 80% of people living in Africa (4). A 
medicinal plant has been described as any 
plant in which one or more of its parts contain 
substances that can be used for therapeutic 
purpose or which acts as precursors for the 
synthesis of useful drugs (5). In Africa, based 
on cultural acceptability and fewer side effects, 
herbal medicine still remains the mainstay of 
treatment in 75-80% of the population at the 
primary health care (6). In Nigeria, thousands 
of plant species are known to have medicinal 
values (5) and the use of different parts of 
several medicinal plants to cure specific ail- 
ments has been in vogue since ancient times 
(7). In the present scenario of emergence of 
multiple drug resistance in human pathogenic 
microorganisms, this has necessitated a search 
for new antimicrobial substances from plants.  
 However, the ability of plants to pro- 
duce many phytochemicals used to perform 
important biological functions is one of the 
many characteristics they possess, and the 
medicinal values of these plants lie in the phy- 
tochemicals present in the plants, which in turn 
produce definite physiological actions in the 
human body (8,9,10). Phytochemicals are non-
nutritive plant chemicals that have protective 
or disease preventive properties. It is a well- 




known fact that plants produce these chemicals 
to protect themselves, and recent researches 
have demonstrated that they can also protect 
humans against various diseases. These chemi- 
cal substances possess varied activities such as 
antioxidant, hormonal, stimulatory, antimicro- 
bial, anti-diarrhoeal, anti-histamine, anti-diabe- 
tic, anti-malarial and anti-carcinogenic effects.  
In most cases, due to the presence of these 
bioactive compounds or phytochemicals, plants 
may be considered as potential candidates for 
developing new antimicrobial drugs or alterna- 
tive treatments of various ailments caused by 
microorganisms resistant to most commonly 
available synthetic drugs.  
 Two efficient medicinal plants that are 
gradually gaining grounds in the developing 
countries due to their medicinal benefits are 
Euphorbia heterophylla and Vitellaria paradoxa. 
E. heterophylla is one of the numerous plants 
found in the field, which grows in disturbed 
localities as a weed of cultivation and waste 
land, in gardens, and along roadsides from 
sea-level up to 3000 m altitude (11). It belongs 
to the family of Euphorbiaceae, and is referred 
to as Mexican fire plant, milk weed and Spurge 
weed in English, and commonly called Nono-
kunchiya in Hausa, Egele in Ibo and Adimeru 
among the Yoruba tribes in Nigeria (12). All the 
parts of E. heterophylla contain latex (11), and 
the plant is widely used in traditional African 
medicine and elsewhere in tropical countries. 
Generally, this plant is regarded as a purgative, 
anti-asthmatic, anti-inflammatory and an abor- 
tifacient (13,14), and has also been reported to 
be oxytocic (15). In East Africa, the roots are 
used in the treatment of gonorrhoea and to 
increase milk production in breast-feeding 
women (15).  Vitellaria paradoxa on the other 
hand, is generally regarded as a deciduous and 
multipurpose plant, found and used in Africa. 
The size of the mature tree of V. paradoxa 
varies from 7 to 25m.This plant belongs to the 
family Sapotaceae and is said to produce shea 
butter as its main product (16). V. paradoxa 
was formerly called Butyrospermum parkii 
(which means butter seed) but could also be 
called Butyrospermum paradoxa. In Nigeria, it 
is locally known as 'emi-emi’ among the 
Yorubas, ′ka’danya′ among the Hausas and 
'okwuma' among the Igbos (17). The plant is 
said to possess white latex. The shea tree 
grows naturally in the wild in the dry savannah 
belt of West Africa from Senegal in the west to 
Sudan in the east, and onto the foothills of the 
Ethiopian highlands. The roots are used as 
chewing sticks in Nigeria, which is common in 
savannah areas (17). Roots and root barks are 
ground to paste and taken orally to cure jaun- 
dice, stomach ache and diarrhoea or can be 
boiled and pound into paste to treat chronic 
sores (17,18). These plants generally are used 
for the treatment of diseases caused by enteric 
bacteria which are known to be associated with 
high morbidity and mortality in humans.
 Enteric bacteria are usually Gram-neg- 
ative bacteria which are mostly gastrointestinal 
flora but can cause diarrhoea or other diseases 
(19). They are also found in various natural 
habitats aside the intestinal tract. Most enteric 
bacteria are motile by peritrichous flagella with 
two major exceptions; Klebsiella and Shigella, 
which lack peritrichous flagella (20). Many of 
the enteric bacteria are facultatively anaerobic 
in nature, a trait that allows them to thrive in 
the gut environment, and most produce energy 
by metabolizing sugars into lactic acid. Some of 
the enteric bacteria live in the gut without 
causing diseases in individuals with good host 
immune system while some almost always 
cause enteric diseases manifesting with symp- 
toms and signs such as vomiting, diarrhoea, 
and other related features (19). Based on the 
health-related threats pose by these enteric 
bacteria, individuals in the populace tend to 
overuse and misuse available synthetic drugs, 
which thereby lead to emergence of resistance 
in the population of these enteric bacteria. It is 
therefore imperative to seek other alternative 
sources of remedy to various enteric diseases 
and determine the differences between them, 
which forms the main objective of this study. 
 
Materials and method: 
 
Collection and identification of plant materials 
 Fresh samples of the roots of both 
plants (Euphorbia heterophylla and Vitellaria 
paradoxa) were collected from Garatu, in a 
village called Anguwan noma, which lies on 
longitude 6.44oN and latitude 9.4oE. The plant 
samples were identified and confirmed at the 
Department of Biological Sciences, Federal Uni- 
versity of Technology, Minna, Nigeria.  
 
Extraction procedure 
 The roots of both plants were thorou- 
ghly washed, air dried at room temperature 
(28oC), and ground into coarse powder using a 
sterile mortar and pestle. The dried roots were 
further ground into a fine powder using an 
electric blender, which was done to enhance 
the penetration of the extracting solvent to 
facilitate the release of the active components 
(21). One hundred grammes (100 g) of each 
ground root was macerated successively for 
three days (with occasional shaking) using cold 
maceration technique. One liter (1000 ml) each 




of distilled water, methanol, chloroform, and 
petroleum ether were used as the extraction 
solvents. The macerated samples were sieved 
with muslin cloth and evaporated to dryness 
using a steam bath. The dried extracts were 
weighed and stored in sterile sample bottles 
and kept in the refrigerator for further studies 
(21).  
 Extracts were reconstituted by dissol- 
ving different weights of each dried extract 
(0.05g, 0.1g, 0.15g and 0.2g) in 1 ml of either 
distilled water or dimethyltetrasulphuric acid 
(DMSO4), to give concentrations of 50 mg/ml, 
100 mg/ml, 150 mg/ml and 200 mg/ml respec- 
tively. Similarly, the standard antibiotic (cipro- 
floxacin) was reconstituted by dissolving diffe- 
rent weights of the dry antibiotic powder (0.05 
g, 0.1g, 0.15g and 0.2g) in 1 ml of distilled 




 The phytochemical screenings of the 
crude extracts of both roots were carried out to 
detect the presence or absence of some secon- 
dary metabolites according to previously descr- 
ibed methods (22,23). 
 
Test bacteria and culture media 
 The test organisms (Salmonella typhi, 
Shigella flexneri, Escherichia coli and Proteus 
vulgaris) were obtained from the stock cultures 
of the Microbiology Laboratory, General Hosp- 
ital, Minna, Niger State, Nigeria. MacConkey, 
Salmonella-Shigella (SS) and Nutrient agar 
plates were used as differential, selective and 
for susceptibility testing media of the test 
bacteria as previously described (24). 
 
In vitro antibacterial assay of crude extracts 
 A 24-hour well-grown activated cultu- 
res of each test bacterium were serially diluted 
in test tubes with normal saline and standar- 
dized with MacFarland turbidity standards to 
obtain inoculum equivalent to 1.0x105 CFU/ml. 
The antibacterial assay of the crude extracts of 
the roots of both plants was done using the 
agar (punch hole) diffusion method as descri- 
bed by Idu and Igekele (24). The Nutrient agar 
plates were prepared by dispensing 20ml of 
sterile molten nutrient agar into sterile Petri 
plates and allowed to set, and then inoculated 
with the standardized inoculum of each test 
bacterium using sterile cotton swab. A 4 mm 
sterile cork-borer was used to punch five (5) 
adequately spaced holes in each inoculated 
agar plates to create wells. Approximately 0.2 
ml of the different concentrations (50mg/ml, 
100mg/ml, 150mg/ml and 200mg/ml) of the 
extracts and the standard antibiotic, was intro- 
duced into each well. The Petri plates were 
incubated at a temperature of 37oC for 24 
hours, after which diameter of inhibition zones 
around each well was measured with a calib- 
rated ruler. The diameters of inhibition zones 
produced by the extracts were compared with 
that produced by the standard antibiotic (cipro- 
floxacin) used as control (24). Extracts of each 
plant that showed little or no antibacterial 
activity were excluded for the in vivo assay.        
 
In vivo antibacterial activity of crude extracts  
 
Experimental animals     
 Inbred mice within the age of 8-12 
weeks with body weight from 18-22 g were 
acquired from Ibrahim Badamosi Babangida 
University Lapai, Nigeria. The mice were kept 
in standard cages with adequate food, water 
and under hygienic conditions for 2 weeks 
before inoculation (25).  
Preparation of inoculum of test bacteria 
 A loopful of the test bacteria was 
inoculated on Salmonella-Shigella agar which 
was incubated aerobically at 37oC to activate 
the them. Colonies of the test bacteria were 
then transferred into test tubes containing 10 
ml of sterile nutrient broth and incubated at 
37oC for 18-24 hours. The culture was serially 
diluted in test tubes with normal saline and 
standardized with McFarland turbidity stan- 
dards to obtain inoculum equivalent to 1.0× 
105 CFU/ml (26). 
Inoculation of mice with test organisms and 
administration of plant extracts and standard 
antibiotic  
 The mice were divided into 28 groups, 
with each group containing 5 mice (n=5). In 
each group, 1 ml of the standardized inoculum 
(containing 1.0x105 CFU as infective dose) of 
each of the test bacterium (E. coli, S. typhi, S. 
flexneri, and P. vulgaris) was introduced into 
each mouse intraperitoneally (26). After 72 
hours, inoculated mice in each group were 
administered daily with 2,000 mg/kg/body 
weight of chloroform, methanolic and aqueous 
root extracts of E. heterophylla and V. para- 
doxa, and the control (ciprofloxacin) antibiotic, 
orally for 7 days (27). The mice were closely 
observed daily after inoculation and the morta- 
lity rate and other physical manifestations were 
recorded. 
 
Observation of physical manifestations, survival 
and mortality  
 The mortality and survival rates of the 
mice in the groups were calculated as numbers 




of mice that died and survived during the 
course of the experiment in relation to all the 
mice that were used (26). The animals were 
observed for frequency, consistency, and the 
colour of their faecal wastes, and for abnormal- 
lities and physical manifestations such as loss 
of appetite, weight loss and body weakness, 
during the period of the experiment (27). At 
the end of the study, infected mice were 
sacrificed using chloroform and buried, to 
prevent the spread of the infection associated 
with enteric pathogens in the environment (27) 
 
Statistical analysis   
 Data were presented as mean ± stan- 
dard error of mean, and analyzed using the 
Statistical Analysis System (SAS) version 9.4. 
Associations between variables were deter- 
mined using analysis of variance (ANOVA), with 




Phytochemical constituents of root extracts of 
the plants      
 The phytochemical components of E. 
heterophylla roots were alkaloids, flavonoids, 
saponins, tannins and cardiac glycosides with 
all the crude extract solvents while compounds 
such as carbohydrates and starch were mostly 
found in V. paradoxa (Table 1).  
 
In vitro antibacterial activity of extracts and 
control antibiotic    
 Tables 2.1 to 5.2 represent the mean 
diameters of the inhibition zones of chloroform, 
methanol, petroleum ether and aqueous extr- 
acts of V. paradoxa and E. heterophylla, and 
the control (ciprofloxacin) antibiotic, on all the 
bacterial strains (S. typhi, S. flexneri, E. coli 











 The tables show dose-dependent anti- 
bacterial activity of the root extracts of both V. 
paradoxa and E. heterophylla on all the bac- 
terial strains and for all the extracting solvents 
(except petroleum ether) as shown by the 
progressive increase in mean diameters of inhi- 
bition zones, with increasing doses from 50 
mg/ml to 200 mg/ml of the extracts. However, 
methanol, aqueous and chloroform root extr- 
acts of V. paradoxa (VPMR, VPAR and VPCR) 
had significantly higher antibacterial activity (p 
<0.05) on all the test bacteria as shown by 
significantly wider mean diameters of inhibition 
zones from 50 mg/ml to 200 mg/ml extract 
concentrations, compared to methanol, aque- 
ous and chloroform root extracts of E. hetero- 
phylla (EHMR, EHAR and EHCR).   
 The antibacterial activity was highest 
for methanol root extract of both E. hetero- 
phylla and V. paradoxa followed by aqueous 
and chloroform root extract, while petroleum 
ether root extracts of both V. paradoxa (VPPR) 
and E. heterophylla (EHPR) showed the least 
antibacterial activity from 50 mg to 200 mg/ml 
extract concentrations as shown by the narrow- 
west diameters of inhibition zones compared to 
the root extracts of the three other solvents. 
Hence, petroleum ether root extract was exclu- 
ded from the in vivo experiment. The anti- 
bacterial activity of the control antibiotic (cip- 
rofloxacin) was however significantly higher 
(wider diameters of inhibition zones) than the 
different solvent root extracts of the two plants 
at all the concentrations tested, although this 
was not in a dose-dependent manner. 
  








                  
 
In vivo antibacterial activity of the extracts  
 Fig 1 represents the in vivo effects of 
chloroform, methanol and aqueous extracts of 
V. paradoxa and E. heterophylla on mice infec- 
ted with S. typhi showing antibacterial activity 
of the extracts in the order E.h/M>V.p/M> 
E.h/A>V.p/C>V.p/A>E.h/C. This indicates that 
methanol extracts of E. heterophylla demon- 
strated the greatest in vivo antibacterial acti- 
vity resulting in only 20% of the infected mice 
having diarrhoea between 1-3 days, and none 
(0%) manifesting pathological symptoms of 
diarrhoea, weight loss, loss of appetite and 
body weakness after 4 days of extract admini- 
stration. Comparatively, chloroform extract of 
E. heterophylla demonstrated the least in vivo 
activity as shown by high percentage (40-60%) 
of infected mice showing pathological symp- 
toms of diarrhoea, weight loss, loss of appetite 
and body weakness after 4 days, and up till the 
7th day of extract administration.  
 Fig 2 presents the in vivo effects of the 
extracts of V. paradoxa and E. heterophylla on 
mice infected with S. flexneri showing anti- 
bacterial activity of the extracts in the order 
E.h/M>V.p/M>V.p/A>E.h/C>E.h/A>V.p/C. The 
methanol extracts of E. heterophylla demon- 
strated the highest in vivo antibacterial activity 
with only 40% and 20% of the infected mice 
manifesting diarrhoea symptoms between 1-3 
days and 4-6 days respectively, and none (0%) 
showing symptoms of weight loss, loss of app- 
etite and body weakness after 5 days of extract 
administration. Conversely, chloroform extracts 
of V. paradoxa demonstrated the lowest in vivo 
activity as shown by the high percentage (80 
%) of infected mice showing symptoms of 
diarrhoea in 1-3 days and 4-6 days, and 40% 
showing symptoms of weight loss, loss of app- 
etite and body weakness after 5 days and up 
till the 7th day of extract administration. 
 Fig 3 represent the in vivo effects of 
the extracts of V. paradoxa and E. heterophylla 
on mice infected with E. coli showing anti- 
bacterial activity of the extracts in the order 
E.h/M>V.p/M>E.h/A>V.p/A>V.p/C>E.h/C. The 
methanol extracts of E. heterophylla demon- 
strated the highest in vivo activity with only 
60% and 20% of infected mice showing patho- 
logical symptoms of diarrhoea in 1-3 days and 
4-6 days respectively, while none (0%) showed 
symptoms of diarrhoea, weight loss, loss of 
appetite and body weakness after 5 days of 
extract administration. However, chloroform 
extracts of E. heterophylla demonstrated the 
lowest in vivo activity as shown by the high 
percentage of infected mice (100%) mani- 
festing diarrhoea symptoms in 1-3 days, and 
40% with diarrhoea, weight loss, loss of appe- 




tite and body weakness after 4 days and up till 
the 7th day of extract administration.  
 Fig 4 represent the in vivo effects of 
the extracts of V. paradoxa and E. heterophylla 
on mice infected with P. vulgaris showing anti- 
bacterial activity of the extracts in the order 
E.h/M>V.p/M>E.h/A>V.p/A>V.p/C>E.h/C. The 
methanol extracts of E. heterophylla demon- 
strated the highest in vivo activity with only 
60% and 20% of infected mice showing patho- 
logical symptoms of diarrhoea in 1-3 days and 
4-6 days respectively, and none (0%) showed 
symptoms of diarrhoea, weight loss, loss of 
appetite and body weakness after 5 days of 
extract administration. However, chloroform 
extract of E. heterophylla demonstrated the 
lowest in vivo activity as shown by the high 
percentage of infected mice with diarrhoea 
(60%) having diarrhoea in 1-3 days and 40% 
with diarrhoea, weight loss, loss of appetite 
and body weakness after 4 days and up till the 

















 The basis of the therapeutic activities 
of plants lies on the phytochemical components 
contained in them (28), which implies that 
variations observed among the phytochemicals 
of the different plants will result in differences 
in their antibacterial activities. Thus, in this 
study, different phytochemicals were extracted 
in varying proportions by the solvents from the 
roots of the plants. Crude extracts of the roots 
of both E. heterophylla and V. paradoxa by the 
different solvents (chloroform, methanol, petr- 
oleum and water) contain cardiac glycosides, 
saponins, alkaloids, flavonoids, and tannins but 
V. paradoxa contain more carbohydrates and 
starch, and less of phlobatannins, compared to 
E. heterophylla. This is similar to the findings of 
Onwuliri (29), who observed the presence of 
phytochemicals such as phlobatannins, alka- 
loids, saponins, phenolics, tannins, and cardiac 
glycosides in tropical plants growing in Nigeria, 
some of which have been shown to exhibit 
varying biological activities, and medicinal pro- 
perties (30). Mensah et al., (31) reported the 
importance of alkaloids, saponins and tannins 
in production of antibiotics used in treating 
common pathogenic microorganisms, which 
have also been known to produce definite 
physiological actions in the human body (32). 
The presence of cardiac glycosides indicates 
that they may act as good sedatives and anti- 
spasmodics (33). Schneider and Wolfhing (34) 
reported the therapeutic effects of some phy- 
tochemical constituents such as tannins and 
cardiac glycoside against cardiovascular dise- 
ases and digestive problems. Therefore, the 
presence of some of these phytochemicals in 
different proportions in the roots of the two 
plants in this study may be responsible for the 
observed in vitro and in vivo antibacterial 
activities.  
 In this study, there was a great dis- 
parity in the results obtained from the anti- 




bacterial activities of the root extracts of both 
E. heterophylla and V. paradoxa in the in vitro 
and in vivo assays, and with regards to the 
different solvents used for extraction. The in 
vitro study showed that root extract of V. 
paradoxa had higher antibacterial activity than 
E. heterophylla for all the extracting solvents 
and on all the test bacteria, while the in vivo 
study showed that the root extract of E. 
heterophylla had higher antibacterial activity 
against infected mice than V. paradoxa, espe- 
cially with methanol as solvent. The reason for 
this disparaging observation is not apparent 
because both plants had comparatively similar 
contents of phytochemicals except that V. par- 
adoxa had more carbohydrates and starch, and 
less phlobatannins, which cannot explain the 
difference in the conflicting antibacterial acti- 
vity. However, the study by Calixto (35) repor- 
ted that differences in antibacterial activity of 
plants could be due to differences in geogra- 
phical location, season of plant, age of the 
plant, and method of extraction, all of which 
can affect the yield and the active constituents 
of medicinal plants. Similarly, differences obs- 
erved in the antibacterial activities of both root 
extracts could be attributed to the penetrating 
effects of the different solvents. Nevertheless, 
methanol appeared the best of all the four 
extracting solvents in this study for both plant 
extracts, and although the antibacterial activi- 
ties of the methanol root extracts of both 
plants were lower compared to the standard 
antibiotic (ciprofloxacin), the finding in our 
study is significant if one considers that only 
crude extraction was done while the probable 
active antibacterial components of the plants 
were not characterized or purified.       
 We noted that 40% of mice infected 
with S. typhi, E. coli and P. vulgaris treated 
with chloroform root extract of E. heterophylla, 
and 40% of mice infected with S. flexneri trea- 
ted with root extract of V. paradoxa showed 
pathological symptoms of watery diarrhoea, 
weight loss, loss of appetite and body weak- 
ness after 4 days, and up till the 7th day of 
extract administration, as compared to the 
groups of infected mice treated with methanol 
and aqueous extracts. The presence of diarr- 
hoea (caused by the inoculated bacteria) in the 
infected mice after 4 days implies that chloro- 
form extract produced poorer yield of the anti- 
bacterial components required for in vivo effi- 
cacy of the two plants, compared to the metha- 
nol and aqueous extracts. Aside this, the pre- 
sence of weight loss, loss of appetite and body 
weakness, which though may be consequen- 
ces of diarrhoea in the infected mice, could also 
be attributed to the physiological adaptation of 
the mice to chloroform, which can lead to low 
appetite and lower caloric intake by the 
animals. This condition has been previously 
reported by Rhiouani et al., (36). Furthermore, 
chloroform and some other extraction solvents 
can trigger abnormal behavioral changes in 
test animals, as reported by Pillai et al., (37), 
who observed reversible treatment-related 
behavioral signs such as apathy and reduced 
locomotor behavior in mice during toxicity test 
with methanolic leaf extract of Plectranthus 




 Crude extracts of E. heterophylla and 
V. paradoxa produce in vitro antibacterial acti- 
vity against the enteric Gram-negative bacteria 
pathogens involved in diarrhoea illnesses, in a 
dose-dependent manner. Methanol extract pro- 
duced the best in vitro and in vivo antibac- 
terial activities for both plants, while chloro- 
form extracts produced the least antibacterial 
effects, and may also have been responsible 
for the physiological adaptations in the mice 
resulting in body weakness, loss of appetite 
and weight loss. Further researches should be 
directed towards isolation and characterization 
of the active compounds in the crude extracts 
  
References: 
          
1. Ghose, T. Earth get greener as globe gets hotter 
live science. 2016; Retrieved on August 10,2017. 
http://www.livescience.com/54579-earth-is-
greening-as-globe-warms.html 
2. Muller, L. P. Importance of secondary metabolites 
constituents as drugs. Phytother. 1973; 3: 354. 
3. Hamburger, M., and Hostettmann, K. Bioactivity in 
plants: the link between phytochemistry and 
medicine. Phytochemistry. 1991; 30: 3864 - 3874. 
4. World Health Organization. Traditional Medicine: 
Growing Needs and Potential, WHO Policy Pers- 
pectives on Medicines. 2002: 1-6. 
5. Sofowora, A. Medicinal plant and traditional 
medicine in Africa. Published in Association with 
Spectrum Books Limited Ibadan, John Wiley and 
Sons, Chinchester, New York. 1982: 66-91. 
6. Ghasi, S., Nwobodo E., and Ofili, J. O. Hypo- 
cholesterolemic effect of crude leaf of Moringa 
oleifera in high fat diet fed wistar rats. J 
Ethnopharmacol. 2000; 69: 21-25. 
7. Rios, J. L., and Recios, M. C. Medicinal plants and 
antimicrobial activity. J Ethnopharmacol. 2005; 
100: 80-84. 
8. Lee, C. K., Kin, H., Moon, K. H., and Shun, K. H. 
Screening and isolation of antibiotic resistance 
inhibitors from herb materials resistance inhibition 
of volatile components of Korean aromatic herbs. 
Arch Pharmaceut Res. 1998; 21: 62-66. 
9. Afolabi, C., Akinmoladun, E. O., Ibukun, I., 
Emmanuel, A., Obuotor E. M., and Farombi, E. O. 
Phytochemical constituent and antioxidant activity 
of extract from the leaves of Ocimum gratissimum. 
Scientific Research and Essay. 2001; 2 (5): 163-
166. 




10. Doughari, J. K., and Manzara, S. In vitro 
antibacterial activity of crude leaf extracts of 
Mangifera indica. Afri J Microbiol Res. 2008; 2: 69-
72 
11. Mosango, D. M. Euphorbia heterophylla L. In: 
Schmelzer, G. H., and Gurib-Fakim, A. (Ed). Prota. 
2008; 11 (1): 1 - 2. 
12. Okeniyi, S. O., Adedoyin, B. J., and Garba, S. 
Phytochemical Screening, Cytotoxicity, Antioxidant 
and Antimicrobial Activities of stem and leave 
extracts of Euphorbia heterophylla. Bull Environ 
Pharmacol Life Sci. 2012; 1 (8): 87-91. 
13. Erden, Y. S., Ekrem, H., Gisho, T., and Yoshiohiro, 
T. Traditional medicine in Turkey IX, folk medicine 
in Northwest Anatolia. J Ethnopharmacol. 1999: 
64: 201. 
14. Falodun, A., Okunrobo, L. O., and Uzoamaka, N. 
Phytochemical screening and anti- inflammatory 
evaluation of methanolic and aqueous extracts of 
Euphorbia heterophylla Linn (Euphorbiaceae). Afr J 
Biotechnol. 2006; 5 (6): 529- 531. 
15. Unekwe, P. C., Ughachukwu, P. O., and Ogamba, 
J. O. Some pharmacological Studies of Aqueous 
extract of leaves of Euphorbia heterophylla. Trop J 
Med Resources. 2006; 10 (2): 1-5. 
16. Djekota, C., Diouf, D., Sane, S., Mbaye, M., and 
Noba, K. Morphological characterization of shea 
tree (Vitellaria paradoxa) populations in the region 
of mandoul in Chad. Int J Biodivers Conserv. 
2014; 6 (2): 184-193. 
17. Orwa, C., Mutua, A., Kindt, R., Jamnadass, R., and 
Simons, A. Agroforestree Database: a tree 
reference and selection guide version 4.0. 2009: 
1-10. 
18. Fobil, J. N., Abbiw, D. K., Attuquayefio, D. K., and 
Adomako, E. Case study: Shea butter in Ghana. 
2002; Retrieved February 3rd, 2014.  
http://www.sheabutterr-naturcreme.de/index.php? 
content=1 
19. Murray, P. R. Enterobacteriaceae. Medical Micro- 
biology. Farrell, R. (Ed.). Mosby Year Book Inc., 
London, UK. 1994: 227-240, 
20. AL_Ouqaili, M. T. S. The Enteric Bacteria. A PhD 
thesis presented at Cairo University.2013: 1-10. 
21. Iyamabo, P. A. Thesis on comparative anti- 
microbial activity of crude extract of Terminalia 
macroptae with phenol chlorhexidine and 
gentamycin. Pharmacognosy J. 1991; 1 (1): 12. 
22. Harborne, J. B. Phytochemical methods; A guide to 
modern techniques of plant analysis. 2nd edition, 
London, Chapman and Hall, London. 1984:1-19, 
37-168. 
23. Trease, G. E., and Evans, W. C. A Text Book of 
Pharmacognosy. EL SB/Bailliere Tindal, Oxford, UK 
1984: 1055.  
24. Idu, M.,  and  Igekele, C. L.  Antimicrobial  activity  
and phytochemistry of Khaya senegalensis root. 
Int J Ayurvedic Herb Med. 2012; 2 (3): 416-422. 
25. Canadian Council on Animal Care (CCAC). Guide- 
lines on animal use protocol review. 1997: 1-5.  
26. Eman, M. A., and Hoda, M. Z. Studies on the effect 
of garlic preparation on Escherichia coli O157:H7 
causing enteritis in lambs. Egyptian J Clin Pathol. 
2008; 21 (4): 102-129. 
27. Itelima, J. U., and Agina, S. E. In vivo 
antimicrobial activity of plant species on Esche- 
richia coli O157:H7 inoculated into albino rats. 
World J Microbiol. 2014; 1 (1): 2-9. 
28. Oyedum, M. U. Phytochemical Screening, In vitro 
and in vivo activity of extracts of parts of Vitellaria 
paradoxa against S. typhi and S. flexneri. An 
unpublished MTech thesis, Federal University of 
Technology, Minna, Niger State, Nigeria. 2015: 56-
59. 
29. Onwuliri, F. C. Antimicrobial studies of the extracts 
of Acalypha wilkesiana L. on microorganisms 
associated with wound and skin infections. West 
Afr J Biol Sci. 2004; 15: 15-19. 
30. Sofowora, A. Medicinal plant and traditional 
medicine in Africa. Published in Association with 
Spectrum Books Limited Ibadan, by John Wiley 
and Sons, Chinchester, New York. 1982; 66-91. 
31. Mensah, J. K., Okoli, R. I., Ohaju-Obodo, J. O., 
and Eifediyi, K. Phytochemical, nutritional and 
medical properties of some leafy vegetables 
consumed by Edo people of Nigeria. Afr J 
Biotechnol. 2008; 7: 2304-2309. 
32. Edeoga, H. O., Okwu, D. E., and Mbaebie, B. O. 
Phytochemical constituents of some Nigerian 
medicinal plants.  Afr J Biotechnol. 2005; 4: 685-
688. 
33. Egunyomi, A., Moody, J. O., Eletu, O. M. Anti-
sickling activities of two ethnomedicinal plant 
recipes used for the management of sickle cell 
anaemia in Ibadan Nigeria. Afr J Biotechnol. 2009; 
8: 20-25. 
34. Schneider, G., and Wolfhing, J. Sherries Medical 
Microbiology. An Introduction to Infectious 
Disease. 4th ed. 2004: 261-273. 
35. Calixto, H. Effect of geographical location on 
antibacterial activity. 2000. Retrieved February 3rd, 
2014. http://www.sheabutterr-naturcreme.de/index. 
php?content=1 
36. Rhiouani, H. R., Nazari, P., Kamli-Nejad, M., and 
Lyoussi, B. Acute and sub-chronic oral toxicity of 
an aqueous extract of leaves of Herniaria glabra in 
rodents. J Ethnopharmacol. 2008; 118: 378 -386. 
37. Pillai, P. G., Suresh, P., Mishra, G., and 
Annapurna, M. Evaluation of the acute and sub- 
acute toxicity of the methanolic leaf extract of 
Plectranthus amboinicus (Lour) Spreng in Balb C 
mice. Euro J Exp Biol.  2011; 1 (3): 236-245. 
 
